Reusora, Judi B.
HRN: 09-54-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/24/2022
CEFUROXIME 750MG (VIAL)
10/24/2022
10/31/2022
IV
750mg
Q8h
Acute Gastritis Vs Uti With Moderate Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes